Surgical pulmonary valve replacement at a tertiary adult congenital heart centre in the current era
2022

Surgical Pulmonary Valve Replacement in Adults with Congenital Heart Disease

Sample size: 490 publication 10 minutes Evidence: moderate

Author Information

Author(s): Kana Kubota, Gerhard-Paul Diller, Aleksander Kempny, Andreas Hoschtitzky, Yasushi Imai, Masaaki Kawada, Darryl Shore, Michael A. Gatzoulis

Primary Institution: Royal Brompton Hospital, London, United Kingdom

Hypothesis

What is the impact of prosthesis type on outcomes after surgical pulmonary valve replacement?

Conclusion

Surgical pulmonary valve replacement is associated with low early mortality and no significant differences in reoperation rates between different types of prostheses.

Supporting Evidence

  • Early mortality rates were low at 1.4%.
  • Freedom from re-intervention rates were 99.8%, 96.6%, 90.2%, and 81.0% at 1, 5, 10, and 15 years, respectively.
  • 27 patients (5.5%) required re-intervention during a mean follow-up of 6.5 years.
  • Survival rates at 1, 5, 10, and 15 years were 98.3%, 97.7%, 96.8%, and 95.4%, respectively.
  • Mosaic valves required earlier re-intervention compared to Perimount valves.

Takeaway

Doctors replaced heart valves in 490 adults with heart problems, and most did well after surgery, with very few needing more surgery later.

Methodology

Retrospective analysis of surgical pulmonary valve replacements performed between January 2003 and December 2018.

Limitations

The study is retrospective and has a relatively short follow-up period.

Participant Demographics

490 patients, mean age 29.9 years, 40% women.

Statistical Information

P-Value

p=0.047

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1016/j.ijcchd.2022.100394

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication